About The Company:
The world today is experiencing a major transformation that occurs once in a century, with opportunities and challenges coexisting, and the wave of the new technological has given birth to many new technologies. Inveedwin was born as a result, aiming to empower the innovative drug track with new quality productive forces and capital drive the industry with both introduced and self-developed technologies, combine various resources, and achieve the maximum commercial value far beyond the industry level, to meet the unsatisfied clinical treatment needs, to benefit patients, to reward shareholders, to return to employees, and thus to achieve multi-party win-win, to realize the great rejuvenation of the Chinese nation and to promote the world's economic development.
About The Team:
The management team of Inveedwin all have extensive experience in serving global renowned manufacturing enterprises MNCs, with rich experience and corresponding resources in R&D clinical registration, government affairs, operation, and commercialization. Adhering to a team style that is pragmatic, reserved, open, and results-oriented, and possessing commercial team with more than a decade of channel accumulation, dare to fight hard battles and can win.
About The Product:
The company focuses on the tumor and self-epidemic track of innovative drugs, and continuously enriches its product pipeline through self-research and introduction.
Nearly 20 years of experience in the pharmaceutical industry. Worked in well-known companies such as Hansoh Pharma, TYKmedicines, Greenleaf, and Jimin Kexin, holding positions in project management, product strategy, and international business. Driven the establishment and research and development management of more than 40 new drug projects, among which more than 10 products been successfully launched. Facilitated the conclusion of more than 10 new drug licensing transactions, with a cumulative contract amount of more than2 billion US dollars
Duke University MBA, Undergraduate in Clinical Medicine from Shanghai Jiao Tong University. Has worked in multiple multinational companies including Astellas, Boehringer Ingelheim, Sanofi, AstraZeneca, Roche, etc., in marketing management position. Over 25 years of experience in market development, brand promotion, and marketing management of innovative drugs. Years of in the field of oncology, especially in lung cancer, digestive tract tumors, urogenital tumors, breast cancer, etc. Riven the successful launch, healthcare access, brand promotion, and academic marketing of multiple products (including small molecules, monoclonal antibodies, and ADCs) in
PhD from the University of Montpellier, France, MBA from the National Academy of Sciences of Peking University, Bachelor of Clinical Medicine from'an Jiaotong University . Has worked in several well-known pharmaceutical companies, including Janssen, Novartis, andHengrui, holding senior management positions in medical affairs and clinical operations . Over 30 years of experience in clinical medical research and clinical of innovative drugs . Managed more than 30 registration clinical studies of innovative drugs and more than 100 post-marketing studies of new drugs . Promoted the successful launch of more than 10 innovative drug products in the fields of NSCLC, re cancer, autoimmune, ophthalmology, and cardiovascular
CMA Worked in well-known multinational companies such as Coca-Cola, holding financial and corporate management for more than 20 years. Possesses extensive experience in financial management, business operations, and government affairs management. Accumulated rich practical experience in corporate operations management and coordination of functions during the entrepreneurial journey.
